Reclassification rates are higher among African American men than Caucasians on active surveillance

Urology

Volumn 85, Issue 1, 2015, Pages 155-160

  Sundi, Debasish ^a   Faisal, Farzana A ^a   Trock, Bruce J ^a   Landis, Patricia K ^a   Feng, Zhaoyong ^a   Ross, Ashley E ^a   Carter, H Ballentine ^a   Schaeffer, Edward M ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AFRICAN AMERICAN; AGED; ARTICLE; BODY MASS; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER REGISTRY; CANCER SIZE; CANCER STAGING; CAUCASIAN; CONTROLLED STUDY; GLEASON SCORE; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTION; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SIZE; RACE; BIOPSY; CLASSIFICATION; COMPARATIVE STUDY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; WATCHFUL WAITING;

AFRICAN AMERICANS; AGED; BIOPSY; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; WATCHFUL WAITING;

EID: 84919389350     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.08.014     Document Type: Article

References (21)

1. NCCN Clinical Practice Guidelines in Oncology: Prostate cancer Natl Compr cancer Netw 2012 Version 3. Available at: NCCN.org
2. A. Heidenreich, J. Bellmunt, and M. Bolla EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2011 61 71
3. J.J. Tosoian, B.J. Trock, and P. Landis Active surveillance program for prostate cancer: an update of the Johns Hopkins experience J Clin Oncol 29 2011 2185 2190
4. M.A. Dall'era, P.C. Albertsen, and C. Bangma Active surveillance for prostate cancer: a systematic review of the literature Eur Urol 62 2012 1 8
5. V. Iremashvili, M.S. Soloway, and D.L. Rosenberg Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance J Urol 187 2012 1594 1599
6. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 Cancer J Clin 62 2012 10 29
7. J.W. Moul, I.A. Sesterhenn, and R.R. Connelly Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men JAMA 274 1995 1277 1281
8. R.F. Sanchez-Ortiz, P. Troncoso, and R.J. Babaian African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men Cancer 107 2006 75 82
9. I.J. Powell, C.H. Bock, and J.J. Ruterbusch Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity J Urol 183 2010 1792 1796
10. G. Chornokur, K. Dalton, and M.E. Borysova Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer Prostate 71 2011 985 997
11. S.D. Ellis, B. Blackard, and W.R. Carpenter Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina Cancer 119 2013 2282 2290
12. D. Sundi, A.E. Ross, and E.B. Humphreys African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them? J Clin Oncol 31 2013 2991 2997
13. M.R. Abern, M.R. Bassett, and M. Tsivian Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center Prostate Cancer Prostatic Dis 16 2013 85 90
14. S.L. Conti, M. Dall'era, and V. Fradet Pathological outcomes of candidates for active surveillance of prostate cancer J Urol 181 2009 1628 1633 discussion 1633-4
15. K.S. Tseng, P. Landis, and J.I. Epstein Risk stratification of men choosing surveillance for low risk prostate cancer J Urol 183 2010 1779 1785
16. V. Iremashvili, J. Burdick-Will, and M.S. Soloway Improving risk stratification in patients with prostate cancer managed by active surveillance: a nomogram predicting the risk of biopsy progression BJU Int 112 2013 39 44
17. D. Sundi, O.N. Kryvenko, and H.B. Carter Pathological examination of radical prostatectomy samples in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men J Urol 191 2013 60 67
18. R.R. Reams, K.R. Kalari, and H. Wang Detecting gene-gene interactions in prostate disease in African American men Infect Agent Cancer 6 suppl 2 2011 S1
19. C. Magi-Galluzzi, T. Tsusuki, and P. Elson TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients Prostate 71 2011 489 497
20. I.J. Powell, G. Dyson, and S. Land Genes associated with prostate cancer are differentially expressed in African American and European American men Cancer Epidemiol Biomarkers Prev 22 2013 891 897
21. M.A. Kinseth, Z. Jia, and F. Rahmatpanah Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes Int J Cancer 2013 1 31